NILO Therapeutics is modulating the immune response via activation of neural circuits to develop therapies for autoimmune and inflammatory diseases. NILO Therapeutics is backed by The Column Group and is currently in stealth mode, so they have not publicly disclosed their research yet.

NILO Therapeutics

(Sr) Research Associate / Data Engineer, Data Science

Senior Accounting Manager

Senior/Principal Scientist, Medicinal Chemistry

Could Food Allergies Be Reversed? These Immune Cells May Hold the Key - SciTechDaily

A look at biotech's year of the megaround - Endpoints News

DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund - STAT

Recently Discovered Immune Cell Type Is Key to Understanding Food Allergies - NYU Langone Health

A Neural Thermostat Sets the Intensity of Immune Responses - The Scientist

Molecular Biology Alum Leverages CC Science Education at Biotech Startup – The Peak - Colorado College

NILO Therapeutics

About: